KOL Perspectives: Biologic Agents to Aid in Therapeutics Development for Mid-to-Late Stage of Lupus
Systematic lupus erythematosus (SLE) or Lupus is a life-threatening autoimmune disease of unknown cause. The disease is characterized by considerable mortality and morbidity. As Lupus appears in multitude of forms, patients are presented to different specialists which make diagnosis difficult. In the recent times, awareness of the disease has steadily increase and significant research initiatives towards the development of new treatments such as Lupuzor for SLE are expected to leverage growth of novel therapies for Lupus. To comprehend the innovative...
View full press release